Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Olga P. Baranova (Saint Petersburg, Russian Federation), Olga P. Baranova, Lubov Novikova, Alexandra Speranskaya, Valentina Zolotnitskaya, Vitalij Perlej, Alexej Gichkin. Pulmonary thromboembolism (PE) in patients with interstitial lung diseases (ILD). Eur Respir J 2016; 48: Suppl. 60, 3543

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary embolism (PE) in amiodarone-induced pulmonary toxicity (AILT) Source: International Congress 2016 – Orphan diseases II Year: 2016 Difficulties of diagnosis of pulmonary embolism (PE) in patients with lymphangioleiomyomatosis (LAM) Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013 Pulmonary artery dissection (PAD) in a patient with diffuse interstitial lung disease and chronic thromboembolic pulmonary hypertension (CTEPH) Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Scleroderma lung disease: Detection of pulmonary hypertension using pulmonary function tests is problematic in patients with emphysema Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Relation between pulmonary arterial remodeling and parenchymal disease in severe COPD and interstitial lung disease patients Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Comorbidities in patients with the combined pulmonary fibrosis and emphysema syndrome (CPFE) Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Prognostic influence of comorbidities in idiopathic pulmonary fibrosis (IPF) Source: International Congress 2014 – ILDs 2 Year: 2014 Study of factors affecting mortality in ILD cases over 2 years Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Variation in mortality from interstitial lung disease by diagnosis Source: International Congress 2015 – IIPs: orphan Year: 2015 Evolution of an interstitial lung disease MDT: 5.5 years of data Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia Source: International Congress 2015 – Treatment of IPF Year: 2015 Pulmonary artery dilation and increased lung density in systemic sclerosis Source: International Congress 2015 – A more functional view of chest pathology Year: 2015 Neoplasia in patients with ILD; shortened survival Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 The decline in lung function is related to both emphysema and fibrosis extent in patients with idiopathic pulmonary fibrosis (IPF)/ combined pulmonary fibrosis and emphysema (CPFE) Source: International Congress 2014 – ILDs 1 Year: 2014 Relevance of the expert ILD clinical-radiological evaluation of referred cases to the MDT Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Treatment of severe pulmonary hypertension in patients with interstitial lung disease: Results in 72 patients from the “HYPID” prospective study Source: Annual Congress 2013 –Pulmonary circulation: treatment Year: 2013 A case of pulmonary capillary haemangiomatosis (PCH) diagnosed by lung biopsy Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Non-invasive haemodynamic measurement to detect treatment response in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 ILD-India registry: Idiopathic pulmonary fibrosis (IPF) and connective tissue disease (CTD) associated interstitial lung disease (CTD-ILD) Source: International Congress 2016 – Clinical aspects of ILD Year: 2016